Insider · CIK 0001522780

Kaye Edward M. MD

CIK 0001522780 Name as filed on the most recent filing

Filed as Kaye Edward M. MD (31)

48 transaction lines · from 31 filings · filed 2015-03-03 to 2026-08-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

48 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-18 S, Open-market sale Stoke Therapeutics, Inc.STOK 2 lines 402,528, disposed Open Form 4 filing 0001522780-26-000007
2026-06-01 S, Open-market sale Cytokinetics IncCYTK 223,172, disposed Open Form 4 filing 0001061983-26-000066
2025-12-08 S, Open-market sale Stoke Therapeutics, Inc.STOK 3 lines 433,385, disposed Open Form 4 filing 0001522780-25-000010
2025-12-05 S, Open-market sale Stoke Therapeutics, Inc.STOK 3 lines 267,761, disposed Open Form 4 filing 0001522780-25-000009
2025-12-04 S, Open-market sale Stoke Therapeutics, Inc.STOK 2 lines 199,197, disposed Open Form 4 filing 0001522780-25-000009
2025-12-03 S, Open-market sale Stoke Therapeutics, Inc.STOK 2 lines 32,793, disposed Open Form 4 filing 0001522780-25-000008
2025-12-02 S, Open-market sale Stoke Therapeutics, Inc.STOK 2 lines 31,748, disposed Open Form 4 filing 0001522780-25-000008
2025-12-01 S, Open-market sale Cytokinetics IncCYTK 1,872,430, disposed Open Form 4 filing 0001061983-25-000040
2025-11-11 S, Open-market sale Cytokinetics IncCYTK 336,789, disposed Open Form 4 filing 0001061983-25-000031
2025-10-08 S, Open-market sale Stoke Therapeutics, Inc.STOK 750,000, disposed Open Form 4 filing 0001522780-25-000007
2025-10-06 S, Open-market sale Cytokinetics IncCYTK 405,420, disposed Open Form 4 filing 0001061983-25-000008
2025-10-03 S, Open-market sale Stoke Therapeutics, Inc.STOK 1,065,206, disposed Open Form 4 filing 0001522780-25-000004
2025-09-30 S, Open-market sale Cytokinetics IncCYTK 368,761, disposed Open Form 4 filing 0001061983-25-000006
2025-09-03 S, Open-market sale Stoke Therapeutics, Inc.STOK 925,858, disposed Open Form 4 filing 0001415889-25-023590
2025-09-02 S, Open-market sale Cytokinetics IncCYTK 337,800, disposed Open Form 4 filing 0001127602-25-021074
2025-09-02 S, Open-market sale Stoke Therapeutics, Inc.STOK 299,260, disposed Open Form 4 filing 0001415889-25-023590
2025-08-29 S, Open-market sale Stoke Therapeutics, Inc.STOK 20,580, disposed Open Form 4 filing 0001415889-25-023590
2025-08-18 S, Open-market sale Stoke Therapeutics, Inc.STOK 221,154, disposed Open Form 4 filing 0001415889-25-022441
2025-06-05 S, Open-market sale Cytokinetics IncCYTK 116,716, disposed Open Form 4 filing 0001127602-25-016870
2025-03-19 S, Open-market sale Stoke Therapeutics, Inc.STOK 73,661, disposed Open Form 4 filing 0001415889-25-008711
2025-03-18 S, Open-market sale Stoke Therapeutics, Inc.STOK 90,012, disposed Open Form 4 filing 0001415889-25-008711
2024-12-09 S, Open-market sale Stoke Therapeutics, Inc.STOK 88,158, disposed Open Form 4 filing 0001415889-24-028928
2024-12-06 S, Open-market sale Stoke Therapeutics, Inc.STOK 78,837, disposed Open Form 4 filing 0001415889-24-028890
2024-05-20 S, Open-market sale Stoke Therapeutics, Inc.STOK 2 lines 653,529, disposed Open Form 4 filing 0001415889-24-014087
2024-03-19 S, Open-market sale Stoke Therapeutics, Inc.STOK 67,999, disposed Open Form 4 filing 0001415889-24-008683
2022-08-05 S, Open-market sale Cytokinetics IncCYTK 571,400, disposed Open Form 4 filing 0001127602-22-020670
2021-12-23 S, Open-market sale Cytokinetics IncCYTK 675,000, disposed Open Form 4 filing 0001061983-21-000265
2020-12-18 S, Open-market sale Stoke Therapeutics, Inc.STOK 311,640, disposed Open Form 4 filing 0001209191-20-064581
2020-12-17 S, Open-market sale Stoke Therapeutics, Inc.STOK 1,188,360, disposed Open Form 4 filing 0001209191-20-064581
2020-11-27 S, Open-market sale Stoke Therapeutics, Inc.STOK 607,600, disposed Open Form 4 filing 0001209191-20-060751
2020-11-25 S, Open-market sale Stoke Therapeutics, Inc.STOK 642,400, disposed Open Form 4 filing 0001209191-20-060558
2020-10-05 S, Open-market sale Cytokinetics IncCYTK 600,000, disposed Open Form 4 filing 0001061983-20-000161
2017-07-20 S, Open-market sale Sarepta Therapeutics, Inc.SRPT 410,000, disposed Open Form 4 filing 0001209191-17-046038
2016-09-22 S, Open-market sale Sarepta Therapeutics, Inc.SRPT 2,410,740, disposed Open Form 4 filing 0001209191-16-142786
2016-09-19 S, Open-market sale Sarepta Therapeutics, Inc.SRPT 3 lines 1,217,600, disposed Open Form 4 filing 0001209191-16-142357
2016-09-14 S, Open-market sale Sarepta Therapeutics, Inc.SRPT 736,710, disposed Open Form 4 filing 0001209191-16-141771
2015-02-27 P, Open-market purchase Sarepta Therapeutics, Inc.SRPT 9,452, acquired Open Form 4 filing 0001325812-15-000019

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 47
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kaye Edward M. MD, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001522780

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.